Explore the full directors' dealings record of Senti Biosciences, Inc., a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €31.2m. The latest transaction was reported on 14 March 2025 (C). Among the most active insiders: Rajangam Kanya. All data is openly available.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€20,568
2 ops.
Sell Volume
42Σ signal
Buys ·€20,568 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.